logo

Cancer

Share

One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.

pharma-032918.jpg A study conducted on mice by researchers of the University of Montreal, led by Jean-François Côté, have found a link between a certain protein called AXL and metastases in HER2-positive breast cancer.

CancerFree-NakedMoleRats-020918.jpg There are a number of interesting facts about naked mole rats, which are natives to East Africa. Of the many interesting facts about naked mole rats, their long cancer-free life has puzzled researchers. The lifespan of naked mole rats is 10-30 years, while its cousins - rat and mice- can live only up to 4 years, and are very prone to tumors.

Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP. The approval for...

JOHNSONS-babyPowder-Lawsuit-102517.jpg A federal judge has reversed a record $417 million jury verdict against health giant Johnson & Johnson. The judge ruled in favor of the pharma company overturning the hefty financial verdict awarded to plaintiffs who claimed that the company's Baby Powder and Shower to Shower powder products caused...

Drug maker AstraZeneca (AZN) announced the full results of Phase III FLAURA trial, which support TAGRISSO's clear potential as a new standard of care (SoC) in the 1st-line treatment of adult patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung...

Genentech, a member of the Roche Group (RHHBY), said that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application or sBLA and granted Priority Review for Gazyva or obinutuzumab in combination with chemotherapy followed by Gazyva alone for people with...

JNJ-lawsuit-082117.jpg Johnson & Johnson (JNJ) has been ordered to pay $417 million to a woman who claims to have developed ovarian cancer after using the company's talc products for feminine hygiene. The Los Angeles Superior Court jury passed the verdict in favor of California resident Eva Echeverria. It is the largest...

Follow RTT